Litcius/Paper detail

Ginsenoside Rd Inhibits Glioblastoma Cell Proliferation by Up-Regulating the Expression of miR-144-5p

Guomin Liu, Tiancheng Lu, Maolei Sun, Wen-Yuan Jia, Xuan Ji, Yungang Luo

2020Biological and Pharmaceutical Bulletin29 citationsDOIOpen Access PDF

Abstract

miR-144-5p exhibits anti-tumor activities in various cancers. Although treatment for glioblastoma has progressed rapidly, novel targets for glioblastoma are insufficient, particularly those used in precision medicine. In the current study, we found that ginsenoside Rd reduced the proliferation and migration of glioblastoma cells. Ginsenoside Rd up-regulated the tumor-suppressive miR-144-5p in glioblastoma cells. Moreover, Toll-like receptor 2, which is a target of miR-144-5p, was down-regulated. After inhibition of miR-144-5p, the effect of Ginsenoside Rd on proliferation inhibition and down-regulation of Toll-like receptor 2 was reduced. These data demonstrated the ginsenoside Rd/miR-144-5p/Toll-like receptor 2 regulatory nexus that controls the glioblastoma pathogenesis of glioblastoma. Our work provided novel targets for glioblastoma diagnosis and treatment.

Topics & Concepts

GlioblastomaGinsenosideCancer researchU87Cell growthReceptorDownregulation and upregulationPharmacologyBiologyMedicineInternal medicineGenePathologyBiochemistryGinsengAlternative medicineGinseng Biological Effects and ApplicationsCancer-related molecular mechanisms researchMicroRNA in disease regulation
Ginsenoside Rd Inhibits Glioblastoma Cell Proliferation by Up-Regulating the Expression of miR-144-5p | Litcius